Decreasing antibiotic over-use by implementation of an antibiotic stewardship programme in preterm neonates in

Anitha Kommalur1, Vidyalakshmi Baddadka1, Sahana Devadas1

  • 1Department of Paediatrics, Vani Vilas Hospital, Bangalore Medical College and Research Institute (BMCRI), Bengaluru, Karnataka, India.

Insights

A quality improvement initiative significantly reduced antibiotic use in preterm neonates by 65% in a resource-limited setting. This antibiotic stewardship program proved safe and effective, decreasing over-prescription without increasing sepsis or mortality.

Area of Science:

  • Neonatal Intensive Care
  • Antibiotic Stewardship
  • Quality Improvement Initiatives

Background:

  • Antibiotic overuse in neonatal sepsis is a critical issue, linked to adverse outcomes.
  • Current antibiotic prescribing rates in neonates are unacceptably high, particularly in resource-limited settings.

Purpose of the Study:

  • To decrease antibiotic over-prescription in preterm neonates.
  • To implement and evaluate an antibiotic stewardship program utilizing a quality improvement (QI) initiative.

Main Methods:

  • A QI initiative was implemented in a neonatal intensive care unit (NICU) in a resource-limited setting.
  • The initiative involved a 1-month baseline, 3 months of Plan-Do-Study-Act (P-D-S-A) cycles, and a 2-month sustainment phase.
  • Antibiotic usage was measured as days of therapy (DOT)/1000 patient days.

Main Results:

  • Antibiotic usage decreased by 65%, from 1464 DOT/1000 patient days to 442 DOT/1000 patient days over 3 months.
  • Key interventions included defining conditions for no antibiotics, revising antibiotic policy, and de-escalation strategies.
  • No increase in culture-positive sepsis or mortality was observed.

Conclusions:

  • A tailored antibiotic stewardship program, implemented via a QI initiative, effectively and safely reduced antibiotic use in preterm neonates.
  • This approach is particularly valuable in resource-limited settings for optimizing antibiotic prescribing.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
83
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
726
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
774
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
69